Unify data from multiple sources into a single portal and automatically detect data discrepancies.
Know the current state of your trials
Obtain actionable notifications and track critical trial metrics in real time to inform strategy.
Empower your team with answers
Leverage genAI to answer clinical, operational, and safety questions based on all of your trial data.
Ask vivo
The first and only solution using the power of genAI to answer questions about your clinical trials
With your data unified into a single source of truth, you can answer your most complex questions in seconds - using plain language. No spreadsheets. No SQL code. No emails.
Actionable Insights
Optimize clinical operations with real time notifications
Vivo provides actionable notifications to keep trials on budget and on time while providing oversight of all data. Vivo adapts to the unique needs of each clinical development team and trial to maximize relevance and value.
Unified Data
Enhance oversight of complex trials with unified data
Vivo brings together all of your clinical trial data to provide unprecedented levels of oversight and quality assurance. Vivo unifies data from EDCs, COAs, labs, imaging, wearables, and more.
“We are the first and only company in the world to enable genAI as a personal data analyst for insights into live unified clinical trial data. No spreadsheets, no SQL queries, no emails. Data translated to knowledge in real time.”
Angela Holmes, CEO of OmniScience, speaks at The Whale Tank, presented at the 2024 Innovation Network Gathering
Vivo analyzes clinical trial data as it flows in across sources to automatically identify data quality concerns and discrepancies. Automated insights into data concerns as the trial progresses save on data management costs and accelerate the time to database lock.
operational acuity
Gain operational acuity with real time insights and notifications
Gain operational acuity with insights to unified data across sources to better monitor trends, track safety and site engagement, and ensure high quality data.
enrollment forecasting
Track enrollment progress
Vivo enables sponsors to track and forecast enrollment and evaluate scenarios to accelerate recruitment. Proactive notifications reveal when things are going off course.
Portfolio oversight
Vivo for your entire portfolio
Vivo acts as a decision intelligence platform for individual drug candidates and entire portfolios. By integrating data from diverse sources within each trial and summarizing progress and study health at a high level, Vivo can provide actionable insights to inform key strategic decisions.
Vivo eliminates the bottlenecks of manual reporting and fragmented spreadsheets, providing a single source of truth across trial activities. By centralizing access to operational metrics, Vivo simplifies daily workflows, reduces administrative burden, and ensures teams can respond proactively to challenges. This streamlined data access shortens timelines, cuts operational costs, and frees up teams to focus on what matters.
Real-time access to unified safety data enables monitoring teams to maintain seamless oversight across trials. With Vivo, safety monitors can instantly spot trends and anomalies at both the subject and population levels, ensuring faster detection and response to emerging risks. This proactive, data-driven approach strengthens patient safety and aligns sponsors with regulatory requirements.
Slow data disrupts progress and introduces risks to study quality. Vivo resolves this frustration by providing real-time insights into COA, PRO, and other outcome measure performance, while safeguarding the study’s blind. Researchers can track behavior patterns, identify deviations early, and address potential issues before they become impossible to remedy, ensuring the integrity of study outcomes. Vivo’s proactive monitoring tools empower researchers to maintain high data quality and obtain higher integrity results.
High quality data is essential to the success of a clinical trial. Real-time insights into data quality and automatic identification of data discrepancies, both within and across sources, enable data management teams with more efficient paths to high quality data and accelerated time to database lock.
Real-time data combined with generative AI empowers leaders at all levels to obtain immediate answers to questions about their trials. As the first AI assistant designed specifically for clinical development reasoning, Vivo acts as a collaborator helping users quickly assess study progress, identify risks, and think through scenarios. This streamlined access to information fosters agility and data-driven decision-making to accelerate timelines and enhance clinical strategy within and across trials.
Traditional solutions for clinical development are increasingly inadequate.
Clinical trial complexity is growing. Modern trial teams are managing triple the data compared to a decade ago. Despite this, the methods and technologies for handling this data remain largely unchanged, heavily relying on manual processes and disparate systems.
This inefficiency hampers clinical trial operations and jeopardizes data quality, pressing the need for innovation. At OmniScience, we believe data unification is the most critical source of innovation from which numerous opportunities emerge. Here we summarize market trends that have led us to this conclusion and ways that our team is laying the foundation for the future of clinical development.
Contents
Extract more from clinical trial data with next-gen trial oversight and analytics.
› Keeping pace with the clinical trial data explosion
› Increasing situational awareness › Knowing the questions to ask to unlock opportunities for innovation, efficiency, and impact › Rethinking information access in clinical trials
Ask Vivo allows me to get real time answers to all the questions I had spent weeks answering in Excel.
VP, Clinical Operations, CNS focused Biotech
One of the best organizations in the healthcare data field I’ve had the pleasure of working with. Next level data science.
CEO of a digital health company focused in neurodegenerative disorders
Working with OmniScience was a dream. They brought in a dream team with the right expertise at the right time.
CEO of a digital health app for pediatric mental health
We have data science expertise in house, but I wanted to have someone apply the state of the art approaches.
Senior Director for Neuroscience Biomarkers at Top 10 Pharma
Our academic partners didn't give us confidence that they could deliver - only OmniScience had the sophicated tools we needed.
COO of a diagnostic biotech company
Every time we engaged with them - there was just a confidence that we would successfully complete our project. They have the core knowledge we needed.
CSO of a neurodegenerative digital health company
Job well done by everyone. Looking forward to many more engagements like this one.
CEO for an oncology focused medtech
Thank you to the OmniScience team, we now have an incredible foundation to build on top of, to iterate, and to innovate.
Chief Product and Technology Officer for a market intelligence firm
I just wanted to say that it's been an absolute pleasure working with you -- you've been so very helpful, graceful, and efficient.
Director, global market research firm
They have the strategic thinking and the technical expertise. So it's not just one or the other. A lot of places have one or the other.
Chief Strategy Officer of leading digital health company specalizing in wearable and sensor-based devices
I’m amazed at the work, the effort, and the progress ... you have a wonderful team! They are visionaries.
VP of Product for an oncology focused medtech
The benefit of working with a very experienced group: they have all the resources that they need and they can lean on other data scientists within their team.
Co-Founder of an early stage genomics biotech
I'm a big fan of OmniScience - I oversee a team of a few hundred but we didn't have the in-house expertise needed to complete our project.
Head of neuroscience for top 10 pharma company
OmniScience really helped us using the AI/ML capabilities they have to .. consolidate huge volumes of information to bolster our internal wet-lab discoveries.
